Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
| OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
88442029 |
| LAW OFFICE ASSIGNED |
LAW OFFICE 106 |
| MARK SECTION |
| MARK |
http://uspto.report/TM/88442029/mark.png |
| LITERAL ELEMENT |
CONFORM |
| STANDARD CHARACTERS |
YES |
| USPTO-GENERATED IMAGE |
YES |
| MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
| GOODS AND/OR SERVICES SECTION (current) |
| INTERNATIONAL CLASS |
042 |
| DESCRIPTION |
| Platform as a service (PAAS) featuring computer software platforms for metadata management activities, data transformations, data
storage and data quality |
| FILING BASIS |
Section 1(a) |
| FIRST USE ANYWHERE DATE |
At least as early as 01/02/2016 |
| FIRST USE IN COMMERCE DATE |
At least as early as 06/27/2016 |
| GOODS AND/OR SERVICES SECTION (proposed) |
| INTERNATIONAL CLASS |
042 |
| TRACKED TEXT DESCRIPTION |
Platform as a service (PAAS) featuring computer software platforms for metadata management activities,
data transformations, data storage and data quality; Software as a service (SAAS) featuring computer cloud-based integrated software applications for ingestion,
aggregation, storage, integration and analysis of data in the field of pharmaceutical clinical trials |
| FINAL DESCRIPTION |
| Software as a service (SAAS) featuring computer cloud-based integrated software applications for ingestion, aggregation, storage,
integration and analysis of data in the field of pharmaceutical clinical trials |
| FILING BASIS |
Section 1(a) |
| FIRST USE ANYWHERE DATE |
At least as early as 01/02/2016 |
| FIRST USE IN COMMERCE DATE |
At least as early as 06/27/2016 |
| SIGNATURE SECTION |
| RESPONSE SIGNATURE |
/Wei Kong/ |
| SIGNATORY'S NAME |
Wei Kong |
| SIGNATORY'S POSITION |
VP |
| SIGNATORY'S PHONE NUMBER |
6096726636 |
| DATE SIGNED |
02/03/2020 |
| AUTHORIZED SIGNATORY |
YES |
| FILING INFORMATION SECTION |
| SUBMIT DATE |
Mon Feb 03 00:07:27 EST 2020 |
| TEAS STAMP |
USPTO/ROA-XX.XXX.XXX.XX-2
0200203000727626174-88442
029-700395ae9c361182a27a9
91e2c1adcac94aa3793aa7d87
5b07338cdbf6a63e69-N/A-N/
A-20200202235632133488 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
| OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
88442029 CONFORM(Standard Characters, see http://uspto.report/TM/88442029/mark.png) has been amended as follows:
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 042 for Platform as a service (PAAS) featuring computer software platforms for metadata management activities, data transformations, data storage and data quality
Original Filing Basis:
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with
the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 01/02/2016 and first used in commerce at least as early as 06/27/2016 , and
is now in use in such commerce.
Proposed:
Tracked Text Description: Platform as a service (PAAS) featuring computer software platforms for metadata management activities, data transformations, data
storage and data quality;
Software as a service (SAAS) featuring computer cloud-based integrated software applications for ingestion, aggregation, storage,
integration and analysis of data in the field of pharmaceutical clinical trialsClass 042 for Software as a service (SAAS) featuring computer cloud-based integrated software applications for
ingestion, aggregation, storage, integration and analysis of data in the field of pharmaceutical clinical trials
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with
the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 01/02/2016 and first used in commerce at least as early as 06/27/2016 , and
is now in use in such commerce.
SIGNATURE(S)
Response Signature
Signature: /Wei Kong/ Date: 02/03/2020
Signatory's Name: Wei Kong
Signatory's Position: VP
Signatory's Phone Number: 6096726636
The signatory has confirmed that he/she is not represented by an authorized attorney, and that he/she is either: (1) the owner/holder ; or (2) a person or persons with legal authority to bind the
owner/holder; and if he/she had previously been represented by an attorney in this matter, either he/she revoked their power of attorney by filing a signed revocation with the USPTO or the USPTO has
granted this attorney's withdrawal request.
Serial Number: 88442029
Internet Transmission Date: Mon Feb 03 00:07:27 EST 2020
TEAS Stamp: USPTO/ROA-XX.XXX.XXX.XX-2020020300072762
6174-88442029-700395ae9c361182a27a991e2c
1adcac94aa3793aa7d875b07338cdbf6a63e69-N
/A-N/A-20200202235632133488